封面
市場調查報告書
商品編碼
1457036

醫用氣體和設備市場 - 2024年至2029年預測

Medical Gas and Equipment Market - Forecasts from 2024 to 2029

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 110 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

醫用氣體及設備市場預計複合年成長率為9.21%,市場規模從2022年的628.29億美元增加到2029年的1163.74億美元。

醫用氣體及設備被認為是醫療設備的一類,包括氮氣、氧氣、氦氣等。醫用氣體設備市場可分為純氣體、空氣、氧化亞氮、以及包括二氧化碳在內的一種或多種成分的混合氣體三大類。醫療設備包括人工呼吸器、氧氣濃縮機、氣體輸送系統、麻醉儀器、呼吸治療儀、高壓艙、醫用氣瓶等。這些設備在各個醫療領域都很重要,並受到 FDA 等監管機構的品質和安全監管。

癌症、糖尿病、氣喘和心血管疾病等慢性疾病的增加是加速醫用氣體設備市場成長的主要促進因素。此外,早產率的快速上升和呼吸道疾病盛行率的增加,特別是隨著吸菸者數量的增加和污染水平的上升,正在推動市場領域的發展。

此外,各種公共機構的參與支持採用這種醫用氣體設備進一步推動了領域規模的發展。此外,FDA 於 2019 年發布了有關 CGMP 法規更新的公告,包括供應隔間和封閉件的氧氣輸送必需品的新設計,以及易於區分的新顏色和標籤。這進一步降低了風險的氣體污染。

市場促進因素:

  • 醫院需求的增加預計將推動市場成長

醫用氣體和設備在醫院行業中發揮著重要作用,隨著世界各地醫院數量的增加,醫院行業的需求大幅成長。這裡有各種各樣的醫療設備,包括低溫產品、流量計、調節器,甚至醫用空氣壓縮機,為需要重症加護的患者提供高效的治療。因此,這些設備已成為整個醫院(從加護病房(ICU) 到手術室 (OT))的中流砥柱。

隨著醫療保健產業對醫用氣體和設備的需求增加,多個政府基金對醫療保健產業的投資也在增加,推動市場成長。以印度為例,自從政府允許醫療保健產業的外國直接投資(FDI)以來,印度的醫療保健產業一直在快速擴張。根據世界衛生組織(WHO)的數據,自2000年以來,越南人均GDP每成長1%,越南的公共衛生支出就會增加1.7%。

  • 慢性病盛行率上升將加速市場成長

由於慢性呼吸系統疾病、心血管疾病、居家醫療需求、人口老化、重症加護和緊急護理、預防性醫療措施、技術進步以及對呼吸健康的日益關注,醫用氣體和設備市場將持續成長,預計將出現成長。慢性呼吸道疾病(如慢性阻塞性肺病和氣喘)需要醫用氣體(如氧氣)進行治療,而心血管疾病(包括心臟衰竭)可能需要氧氣來治療呼吸困難的患者。人們對家庭醫療保健的日益偏好正在推動對可攜式和家用醫用氣體設備的需求,包括氧氣療法和其他呼吸支援設備。醫用氣體輸送系統和設備的技術進步有助於改善患者照護和慢性病管理。關注呼吸系統健康的公共衛生宣傳活動和舉措也有助於提高對慢性呼吸系統疾病的認知,從而實現早期診斷和治療。

預計北美將佔據大部分市場佔有率

在預測期內,北美市場可能會出現急劇成長。北美醫用氣體設備市場在市場佔有率和收益方面佔據主導地位,預計在預測期內將保持其主導地位。北美地區主要企業的存在以及完善的醫療保健(包括製藥地區)是導致北美在醫用氣體設備市場佔據主導地位的一些促進因素。北美先進的醫療基礎設施、嚴格的監管標準、高昂的醫療成本、技術進步以及日益成長的居家醫療需求,造就了其在醫用氣體和設備行業的主導市場地位。

此外,由於存在多個醫療機構,據說美國的銷售額很高。此外,美國目前家庭治療的使用率不斷增加,導致醫用氣體設備市場的標準甚至分析水準不斷提高,包括各種輸送程序。

目錄

第1章 簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章醫用氣體和設備市場:按類型

  • 介紹
  • 醫用氣體
    • 市場機會和趨勢
    • 成長前景
    • 地域盈利
    • 二氧化碳
    • 氧化亞氮
    • 醫用空氣
  • 醫用氣體設備
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第6章醫用氣體及設備市場:依應用分類

  • 介紹
  • 治療條件
    • 市場機會和趨勢
    • 成長前景
    • 地域盈利
  • 呼吸治療
    • 市場機會和趨勢
    • 成長前景
    • 地域盈利
  • 心血管治療
    • 市場機會趨勢
    • 成長前景
    • 地域盈利
  • 其他
    • 市場機會趨勢
    • 成長前景
    • 地域盈利

第7章醫用氣體和設備市場:依最終使用者分類

  • 介紹
  • 醫院
    • 市場機會趨勢
    • 成長前景
    • 地域盈利
  • 家庭保健
    • 市場機會和趨勢
    • 成長前景
    • 地域盈利
  • 製藥公司
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場機會和趨勢
    • 成長前景
    • 地域盈利

第8章醫用氣體及設備市場:按地區

  • 介紹
  • 北美洲
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 南美洲
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 歐洲
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 中東/非洲
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 亞太地區
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 有競爭力的儀表板

第10章 公司簡介

  • The Linde Group
  • Praxair Technology, Inc.
  • Delta P Srl
  • Rotarex
  • SOL SPA
  • Messer Group
  • Medicop
  • Amico Group of Companies
  • Precision UK Ltd(a subsidiary of Indutrade)
  • MEC Medical Ltd.
  • Air Liquide
  • Air Products and Chemicals, Inc.
  • TAIYO NIPPON SANSO CORPORATION
  • GCE Group
  • Atlas Copco AB
簡介目錄
Product Code: KSI061612247

The medical gas and equipment market is expected to grow at a CAGR of 9.21%, reaching a market size of US$116.374 billion in 2029 from US$62.829 billion in 2022.

Medical gases and equipment are regarded as a category of medical equipment that includes nitrogen, oxygen, and helium among others. The medical gas equipment market can be classified into three categories such as that of pure gas, and mixtures of one or more components including air, nitrous oxide, and carbon dioxide which are regarded to be essential in multiple healthcare and medical applications. Medical equipment includes ventilators, oxygen concentrators, gas delivery systems, anaesthesia machines, respiratory therapy devices, hyperbaric chambers, and medical gas cylinders. These devices are crucial in various medical disciplines and are regulated by regulatory bodies like the FDA for quality and safety.

The rise in a few chronic disorders such as cancer, diabetes, asthma, and cardiovascular disorders will act as a major driver accelerating the medical gas-equipment market's growth rate. Moreover, the upsurge relating to the incidences of preterm births, and the growing prevalence of respiratory diseases, especially on account of the increasing count of tobacco smokers including the mounting pollution level is boosting the market domain.

Moreover, the involvement of the various public organizations in supporting the adoption of this medical gas equipment is further leading to propel the domain size. Additionally, announcements were made by the FDA in 2019, regarding the updating of its CGMP regulations to include a new design which is a necessity of oxygen supply to supply compartments and closure, including a new color and labeling to make them easily distinguishable and to further lead in reducing the risk of gas pollution.

MARKET DRIVER:

  • The rise in demand from hospitals is anticipated to spur the market growth

Medical gas and equipment play an imperative role in the hospital industries which are witnessing a significant surge in demand with the increasing number of hospitals across the globe. To deliver and provide efficient treatment to patients requiring critical care, there are various medical equipment such as cryogenic products, flowmeters, regulators, and even medical air compressors and others as well. This equipment is therefore mainstay in Intensive Care Units (ICUs) to Operation Theatres (OTs) across hospitals.

With such an increase in the demand for medical gas and equipment in the healthcare industry, multiple government funds in healthcare are increasingly investing which is driving the market growth. For instance, taking the example of India, the healthcare sector in India is expanding at a brisk pace, especially since the government has allowed foreign direct investment (FDI) in the industry. According to the World Health Organization (WHO), in Vietnam for every 1% increase in per capita GDP, public spending on healthcare has surged by 1.7% since 2000.

  • Rising incidence of chronic diseases will surge the growth of the market

The medical gas and equipment market is expected to experience sustained growth due to the increasing prevalence of chronic respiratory conditions, cardiovascular diseases, home healthcare needs, the aging population, critical care and emergency medicine, preventive healthcare measures, technological advancements, and increased focus on respiratory health. Chronic respiratory conditions like COPD and asthma require medical gases like oxygen for therapeutic purposes, while cardiovascular diseases, including heart failure, may require oxygen for patients experiencing respiratory distress. The growing preference for home healthcare fuels the demand for portable and home-use medical gas equipment, including devices for oxygen therapy and other respiratory support. Technological advancements in medical gas delivery systems and equipment contribute to improved patient care and management of chronic diseases. Public health campaigns and initiatives focusing on respiratory health also contribute to increased awareness of chronic respiratory conditions, leading to earlier diagnosis and treatment.

North America is anticipated to hold a significant amount of the market share

North America will witness a surge in this market during the projected period. The medical gas equipment market of North America dominates in terms of its market share and market revenue which is said to flourish its dominance during the forecast period. The presence of key players in the North American region along with the well-established healthcare including the pharmaceutical region is the few driving factors leading towards the dominance of North America in the medical gas equipment market. North America's advanced healthcare infrastructure, strict regulatory standards, high healthcare expenditure, technological advancements, and growing demand for home healthcare contribute to its dominant market position in the medical gas and equipment industry.

Additionally, the US is said to account for a higher sales value in the region which is further driven by the presence of multiple healthcare facilities. Furthermore, the current increase in the use of home-based therapy in the US is resulting in the medical gas equipment market experiencing a rise in standards and even analysis including various delivery procedures.

Market Key Developments

  • October 2023- Atlas Copco has acquired William G Frank Medical Gas Testing and Consulting, LLC and Medical Gas Credentialing LLC, both based in Concord, New Hampshire, USA. The acquisitions include medical and laboratory gas services, including annual inspections, consulting, preventative maintenance, parts supply, equipment sales, and professional development and training.
  • November 2022- ESAB Corporation has announced a retail partnership with Northern Tool + Equipment, a leading provider of high-quality tools and equipment. The partnership includes flagship products from ESAB's marquee brands, including ESAB, Victor(R) Gas Equipment, and Tweco(R), available in Northern Tool + Equipment's retail footprint, which includes over 125 stores in the Midwest and East Coast. The products are also available online at northerntool.com, providing welders and fabricators with a convenient purchasing path. The partnership is expected to expand as the companies continue to innovate and optimize their offerings.
  • January 2022- NOVAIR, a leading manufacturer of on-site gas production systems, has acquired OGSI, a USA-based manufacturer of industrial and medical oxygen generators. OGSI's solutions are designed for demanding applications like disaster preparedness, healthcare, and semiconductor manufacturing. As part of NOVAIR Group, OGSI and the US market will access a wide range of high-end solutions, including industrial and medical PSA oxygen & and nitrogen generators, high-pressure oxygen Cylinder Filling Systems, and Medical Air/Vacuum Systems. The acquisition strengthens NOVAIR's global presence and manufacturing capacity, with a new foothold in the USA.

Segmentation:

By Type

  • Medical Gas
  • Oxygen
  • Carbon Dioxide
  • Nitrogen
  • Nitrous Oxide
  • Medical Air
  • Helium
  • Medical Gas Equipment

By Application

  • Therapeutic Condition
  • Respiratory therapy
  • Cardiovascular Therapy
  • Others

By End-User

  • Hospitals
  • Home Healthcare
  • Pharmaceutical Companies
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Medical Gas
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
    • 5.2.4. Oxygen
    • 5.2.5. Carbon Dioxide
    • 5.2.6. Nitrogen
    • 5.2.7. Nitrous Oxide
    • 5.2.8. Medical Air
    • 5.2.9. Helium
  • 5.3. Medical Gas Equipment
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness

6. MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION

  • 6.1. Introduction
  • 6.2. Therapeutic Condition
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Respiratory Therapy
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Cardiovascular Therapy
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Others
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. MEDICAL GAS AND EQUIPMENT MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Home Healthcare
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Pharmaceutical Companies
    • 7.4.1. Market Opportunities and Trends
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness
  • 7.5. Others
    • 7.5.1. Market Opportunities and Trends
    • 7.5.2. Growth Prospects
    • 7.5.3. Geographic Lucrativeness

8. MEDICAL GAS AND EQUIPMENT MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Italy
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Opportunities and Trends
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Others
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. Japan
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. South Korea
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. Others
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. The Linde Group
  • 10.2. Praxair Technology, Inc.
  • 10.3. Delta P S.r.l
  • 10.4. Rotarex
  • 10.5. SOL SPA
  • 10.6. Messer Group
  • 10.7. Medicop
  • 10.8. Amico Group of Companies
  • 10.9. Precision UK Ltd (a subsidiary of Indutrade)
  • 10.10. MEC Medical Ltd.
  • 10.11. Air Liquide
  • 10.12. Air Products and Chemicals, Inc.
  • 10.13. TAIYO NIPPON SANSO CORPORATION
  • 10.14. GCE Group
  • 10.15. Atlas Copco AB